Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)
| 2.20 Data as of Jan 23 |  +0.07 / +3.29%Today’s Change | 1.00 Today|||52-Week Range 8.46 | -13.73% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 33.1K | 5.0M | 3.8M | 8.0M | |
| Depreciation And Amortization | 150.2K | 56.0K | 31.0K | 20.0K | ||
| Operating Expenses | Gross Income | -117.1K | 4.9M | 3.7M | -- | |
| General Expenses | 21.3M | 30.8M | 38.3M | 39.7M | ||
| Research And Development | 14.4M | 22.6M | 29.2M | 28.9M | ||
| Total Operating Expenses | 21.4M | 30.9M | 38.4M | 39.7M | ||
| Non-Operating Expenses | Operating Income | -21.4M | -25.9M | -34.6M | -31.8M | |
| Extraordinary Credit | 0.00 | 5.7M | 0.00 | 96.0K | ||
| Extraordinary Charge | 0.00 | 0.00 | -7.5M | -- | ||
| Interest Expense On Debt | 0.00 | -- | 1.9M | 2.9M | ||
| Other Expenses | -3.2M | 0.00 | 10.0K | -4.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -24.6M | -20.1M | -44.0M | -34.6M | |
| Net Income | -24.6M | -20.1M | -44.0M | -34.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 24.9M | 46.4M | 48.1M | 52.2M | |
| Shares To Calculate EPS Diluted | 24.9M | 46.4M | 48.1M | 52.2M | ||
| Earnings Per Share | EPS | -$5.94 | -$0.43 | -$0.91 | -$0.66 | |
| EPS Diluted | -$1.02 | -$0.43 | -$0.91 | -$0.66 | ||
.